PT Siloam International Hospitals Tbk's quarterly market cap
increased
from Sep. 2025 (€1,259.8 Mil) to Dec. 2025 (€1,558.5 Mil) and
increased
from Dec. 2025 (€1,558.5 Mil) to Mar. 2026 (€1,727.3 Mil).
PT Siloam International Hospitals Tbk's annual market cap
increased
from Dec. 2023 (€1,558.4 Mil) to Dec. 2024 (€2,312.0 Mil) but then
declined
from Dec. 2024 (€2,312.0 Mil) to Dec. 2025 (€1,558.5 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PT Siloam International Hospitals Tbk's Enterprise Value for Today is €1,396.0 Mil.
PT Siloam International Hospitals Tbk (FRA:2LS) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
PT Siloam International Hospitals Tbk Market Cap Related Terms
PT Siloam International Hospitals Tbk Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Siloam International Hospitals Tbk Market Cap Chart
For the Medical Care Facilities subindustry, PT Siloam International Hospitals Tbk's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Siloam International Hospitals Tbk Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Siloam International Hospitals Tbk's Market Cap distribution charts can be found below:
* The bar in red indicates where PT Siloam International Hospitals Tbk's Market Cap falls into.
PT Siloam International Hospitals Tbk Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Siloam International Hospitals Tbk (FRA:2LS) has a Market Cap of €1,339.4 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PT Siloam International Hospitals Tbk and its competitors. According to the industry distribution chart, PT Siloam International Hospitals Tbk ranks #94 out of 697 companies in the Healthcare Providers & Services industry, placing it in the top 13.5%.
Is PT Siloam International Hospitals Tbk's Market Cap too high?
PT Siloam International Hospitals Tbk's current Market Cap is €1,339.4 Mil. Based on the distribution chart, PT Siloam International Hospitals Tbk ranks #94 out of 697 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, PT Siloam International Hospitals Tbk has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Siloam International Hospitals Tbk's Market Cap compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Siloam International Hospitals Tbk ranks #94 out of 697 companies for Market Cap. This places PT Siloam International Hospitals Tbk in the top 14% of its industry — outperforming the majority of peers. The industry median Market Cap is 93.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 93.63, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PT Siloam International Hospitals Tbk and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 93.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Siloam International Hospitals Tbk's current Market Cap is €1,339.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Siloam International Hospitals Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk (FRA:2LS) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.13, compared to a current price of €0.10 — trading 25.8% below its estimated fair value. The current Market Cap is €1,339.4 Mil. PT Siloam International Hospitals Tbk's overall GF Score™ is 91/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For PT Siloam International Hospitals Tbk (FRA:2LS), the current Market Cap is €1,339.4 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Siloam International Hospitals Tbk (FRA:2LS) Overvalued in 2026?
Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk stock appears to be undervalued.
The current stock price of €0.10 is trading 25.8% below its estimated GF Value™ of €0.13.
GuruFocus considers PT Siloam International Hospitals Tbk to be Modestly Undervalued.
Key valuation signals for FRA:2LS:
Market Cap: €1,339.4 Mil
GF Value™: €0.13 vs. price of €0.10 (25.8% below fair value)
No single metric tells the full story. See the FRA:2LS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Siloam International Hospitals Tbk Business Description
PT Siloam International Hospitals Tbk operates a network of hospitals in Indonesia. Its hospitals are located in the Greater Jakarta area and across Java, Sumatra, Kalimantan, Sulawesi, Bali, Nusa Tenggara, Ambon, and other areas across Indonesia, along with several Siloam Clinics. The company offers an integrated, one-stop care ecosystem designed to provide comprehensive healthcare services, spanning examination, diagnosis, clinical management, rehabilitation, and health education. Additionally, it offers special clinical services in the following segments, including neurosciences, neurology, digestive, cardiac, orthopedic, etc., by running the Center of Excellence and specialty centers. The company generates the majority of its revenue by offering hospitalization and outpatient services.
91GF Score
Get the complete analysis for FRA:2LS
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2LS has been successfully added to your 
